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Abstract
Background: The aims of this study are to evaluate and summarize the scientific production in the field of Chinese herbal medicine (CHM)
treatment of cardiovascular disease (CVD).
Methods: A systematic bibliometric search was performed based on the PubMed database covering relative publications between January 1,
1995, and December 31, 2014. Core of the search strategy include the key word cardiovascular disease and the Medical Subject Heading
Chinese herbal medicine. The number, type, country, major journals, and research focus of articles were analyzed in accordance with
bibliometrics methodologies.
Results: The retrieve results were analyzed and described in the form of texts, tables, and graphs. A total of 3,826 articles were identified,
40.28% of which were original articles. All articles were from 50 countries/territories. China was ranked first with 2,258 articles, followed by
Japan with 173 articles. 665 articles were published by Zhongguo Zhong Xi Yi Jie He Za Zhi.
Conclusion: The publication activity of literature has grown rapidly in the past 20 years, indicating enhanced attention and increasing research
input to CHM treatment of CVD. Owing to its great advances in scientific studies, CHM will continue to play an important role in medical
research.
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Introduction
Cardiovascular disease (CVD) is an abnormal function of the heart or blood vessels. It is one of the most dangerous threats to human health
manifested by different clinical types such as coronary heart disease, hypertension, myocardial ischemia-reperfusion injury infarction, heart
failure, cardiac arrhythmia, and so forth (Hu et al., 2010; Huffman et al., 2015; Janse, 2000). According to the World Health Organization
(WHO), CVD is the primary cause of death worldwide, and the number of people who die from CVD every year is more than any other cause of
death (Acar 2010; Daubert 2008; Evora et al., 2014). Although treated with intensive medication or revascularization therapy, uncontrolled
angina and recurrent acute cardiovascular events are still the major problems confronting modern medicine (Cohen et al., 2008; Qiu et al., 2012).
The reasons of CVD are complicated. Many research teams are trying to find the causes and treatment methods. In the past decade, there has
been a great increase in the use of complementary treatments such as herbal remedies in the treatment of disease. Some herbal derivations have
become standard therapy in cardiovascular disease, e.g. digitalis, reserpine and aspirin. The common use of Chinese herbal medicine (CHM) to
treat CVD has a long history and ample experience in some Asian countries (Guo et al., 2013; Tägil et al., 2013). CHM has been studied
extensively and seems to be safe and effective in treating CVD. With modern technology widely used in CHM research, the research of the
treatment of CVD by CHM has also made a great breakthrough.
Bibliometrics analysis is an applied scientific discipline that is systematically conducted to evaluate the relative importance of scientific
production in a specific field. It provides a useful tool to interpret the temporal evolution and geographical distribution of researches on a
specific topic (Michalopoulos et al., 2005; Milanez et al., 2013; Rahman et al., 2005). It has been applied to assess the scientific outputs or
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research patterns of authors, journals, countries, and institutes and to identify international cooperation (Chabowski et al., 2013; Chiu et al., 2007;
Lv et al., 2011). Some studies use bibliometric tools to examine a speciﬁc ﬁeld: Agronomy (Canas-Guerrero et al., 2013), Computer Science 
(Guan et al., 2004; Uriona-Maldonado et al., 2012), nano science and nanotechnology (Zhou et al., 2006), and Clinical Medicine (Saragiotto et
al., 2014). These authors use bibliometrics analysis to present a general view of the scientiﬁc and technological production in different fields. 
This study provides a retrospective bibliometrics analysis of researches on CHM treatment of CVD from 1995 to 2014. The goals of this
study are: (1) identifying general patterns of publication outputs, journals, and subject categories in this field; (2) evaluating national research
performance; (3) summarizing global research trends, which may serve as a potential guide for future research. This article is structured as
follows: The section of materials and methods describes the study design, including data acquisition, search strategy, inclusion criteria and
exclusion criteria, and data analysis; the section of results and discussion shows the evaluate results and discussion; and the last section gives a
brief conclusion.
Materials and Methods
In this study, a systematic bibliometric search was performed based on the PubMed database covering related publications between January
1, 1995, and December 31, 2014. We initially searched for all articles with MeSH Terms including “Cardiovascular System”, “Cardiovascular
Physiological Phenomena”, “Cardiovascular Diseases”, “Cardiovascular Agents”, “Cardiology” and “Drugs, Chinese Herbal”. The final search
strategy was the following: “Cardiovascular System” [MeSH] OR “Cardiovascular Physiological Phenomena” [MeSH] OR “Cardiovascular
Diseases” [MeSH] OR “Cardiovascular Agents” [MeSH] OR “Cardiology” [MeSH] AND “Drugs, Chinese Herbal” [MeSH]”. As a result, a total
of 3,826 articles were identified. Then, specialized analysis software, GoPubMed analytical tools (Doms et al., 2005), and Microsoft Excel 2010
software (Winston 2011) were applied to general data manipulation. The documents were analyzed according to the following indicators: (1)
publication output; (2) publication distribution by countries/territories; (3) type of document; (4) publication patterns; (5) research tendencies
and focus; (6) frequency Chinese medicines.
Results and Discussion
In this study, bibliometrics analysis on published CHM treatment of CVD research articles that are of sufficient quantity and high quality
was conducted. A total of 3,834 articles from 1995 to 2014 (20 years) were identified with 8 articles excluded. The analysis results of this study
are represented in the following graphs and tables:
Publication Output
During the period from 1995 to 2014, 3,826 relative articles were indexed in PubMed. In 1995, 66 articles were published, while in 2013
the number of publications rose to 233. Results of publication output are shown in Figure 1. In the past twenty years, the number of publications
in this area has increased steadily. It is worth noting that the 2014 data may not be comprehensively included up to January, 2015, as this analysis
performed. According to the obvious overall rising trend, it can be predicted that the numbers of articles on CHM prevention and treatment of
diseases will keep growing at a high rate in the future.
Figure 1: The relationship between years and the total number of published papers from 1995 to 2014
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Distribution of Publication by Countries/ Territories
According to the author’s information, of the 3,826 articles published between 1995 and 2014, a total of 50 countries/territories are involved.
China heads the article number ranking with the largest number of articles (2,258, 59.02%), followed by Japan (173, 4.52%), Taiwan (94,
2.46%), and Hong Kong (72, 1.88%). The result shows that Asian countries/territories lead the researches of CHM in the world, particularly
China. Figure 2 illustrates the global distribution of published articles and Table 1 shows top 10 countries / territories. It is not surprising that
China is the most active country on CHM research, whereas the researches in several other countries also thrive. In China, China Academy of
Chinese Medical Sciences, Beijing University of Chinese Medicine, Guang’anmen Hostpital, and Xiyuan Hospital have become the main
scientific research institutions in this area. In the future, multinational collaboration can help CHM researches make more achievements.
Figure 2: Distribution of articles published in the countries/territories
Table 1: Top 10 countries / territories of distribution of articles published
Rank Country/territory Number of publications Percentage (%)
1 China 2,258 59.02
2 Japan 173 4.52
3 Taiwan 94 2.46
4 Hong Kong 72 1.88
5 United States 69 1.80
6 South Korea 66 1.73
7 Singapore 18 0.47
8 United Kingdom 15 0.39
9 Australia 14 0.37
10 Germany 14 0.37
Type of Document
After the analysis of the types of documents, 12 types were identified. Journal article (1,541, 40.28%) was the most frequently used type,
followed by English abstract (1,260, 32.93%), clinical trial (689, 18.01%), comparative study (189, 4.94%), case report (94, 2.46%), comment
(19, 0.50%). From Figure 4, it is evident that the article, abstract and clinical trial constituted the major types of publications relating to CHM
research over this period, which is similar to the results of the bibliometric research based on the PubMed database, and that is the reason why
articles are usually chosen as the document type for analysis.
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Figure 4: Distribution of the document type
Publication Patterns
Zhongguo Zhong Xi Yi Jie He Za Zhi was the most productive journal with 665 publications, followed by Zhongguo Zhong Yao Za Zhi
(385), Zhong Yao Cai (151), Journal of Traditional Chinese Medicine (127), and Journal of Ethnopharmaclogy (126). Table 2 shows the top 10
most active journals with their impact factors. The journal impact factor is computed from JCR report, and is usually used to evaluate the relative
importance of a journal, especially among the same field of journals.
Table 2: The 10 most active journals with the number of articles, impact factor (IF), ISI Journals category, and the position of the journals in its
category
Rank Journal Number Percentage (%) IF 5-year IF Place ofPublication
1 Zhongguo Zhong Xi Yi Jie HeZa Zhi 665 17.38 N/A N/A China
2 Zhongguo Zhong Yao Za Zhi 385 10.06 N/A N/A China
3 Zhong Yao Cai 151 3.95 N/A N/A China
4 Journal of traditional Chinesemedicine 127 3.32 0.667 N/A China
5 Journal of ethnopharmacology 126 3.32 2.939 3.284 Ireland
6 Zhong Xi Yi Jie He Xue Bao 107 2.80 N/A N/A China
7 Chinese Journal of IntegrtiveMedicine 90 2.35 1.401 1.232 China
8 American Journal of Chinesemedicine 68 1.78 2.625 2.119 England
9 Phytomedicine 47 1.23 2.877 3.237 Germany
10 Acta pharmacologica sinica 45 1.18 2.496 2.673 China
IF: impact factor in 2013 JCR; N/A: not available.
Research Tendencies and Focus
The search results were analyzed by using the statistical function of Excel based on the subject terms that are indexed to each article by
PubMed. In these articles, “Herbal Medicines for Cardiovascular Diseases” introduces the research status (Xiong et al., 2014). Other articles
addressed the clinical application and the mechanism of herbal medicines in the treatment of CVD (Li et al., 2009; Liu et al., 2015). In addition,
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European countries, the United States and other developed countries in modern medicine also begin to pay close attention to the researches that
have been published in the literature of these countries. Their attention hotspots mainly are Chinese medicine ingredients and efficacy, and a lot
of researches have been conducted on the molecular level (Sayers et al., 2011; Wheeler et al., 2007) .Table 3 shows the top 10 high-frequency
subject terms of the articles related to the study, by which it can be observed that the recent research focus are mainly pharmacology and
therapeutic use of CHM, Phytotherapy, chemistry and application of Chinese herbal. The results are showed in table 3.
Table 3: Top 10 high frequency MeSH terms
Rank MeSH terms Frequency Percentage (%)
1 Drugs, Chinese Herbal/*pharmacology 226 13.90
2 Drugs, Chinese Herbal/*therapeutic use 171 13.69
3 Drugs, Chinese Herbal/*administration & dosage 81 10.37
4 Drugs, Chinese Herbal/*chemistry 59 10.16
5 *Phytotherapy 49 6.21
6 Apoptosis/drug effects 33 4.54
7 Drug, Chinese Herbal/isolation & purification 458 2.97
8 Salvia miltiorrhiza/ chemistry 427 2.56
9 Cell Proliferation / drug effects 236 2.35
10 Oxidative Stress/ drug effects 233 1.49
Chinese Herbal Medicine in the Treatment of Cardiovascular Disease
In recent years, there has been a great increase in the use of CHM remedies in the treatment of disease. Recently, a great progress has been
made focusing on the effectiveness and safety of herbal medicines in patients with CVD (Li et al., 2012; Tan et al., 204). “Analysis of
Anaphylactic Shock Caused by 17 Types of Traditional Chinese Medicine Injections Used to Treat Cardiovascular and Cerebrovascular
Diseases” (Guo et al., 2015) and “Application of traditional Chinese medicine injection in the cardiovascular and cerebrovascular disease” (Fang
et al., 2011) described pharmacological action mechanism. There still were other articles of relative research (Chen et al., 2014; Huang et al.,
2015; Tian et al., 2015; Xin et al., 2014; Xu et al., 2015). Table 4 shows some common herbal therapies that may affect CVD, according to
clustering analysis.
Table 4: Top 10 herbal medicine
Rank Herbal medicine English name Frequency
1 RenShen Ginseng Radix Et Rhizoma 304
2 DanShen salvia miltiorrhiza 197
3 SanQi Notoginseng Radix Et Rhizoma 134
4 BaiGuo Ginkgo Semen 108
5 HuangQi Astmgali Radix 60
6 DangGui Angelicae Sinensis Radix 37
7 JuHua Chrysanthemi Flos 32
8 ChuanXiong Chuanxiong Rhizoma 27
9 ChaShuGen Tea root 24
10 HuangLian Coptidis Rhizoma 21
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Conclusion
In this study, we summarized and analyzed the literature of CHM treatment of CVD in PubMed from 1995 to 2014. In the past twenty
years, the number of publications in this area has increased steadily. The results show that CHM plays an important role in treating CVD. Many
researches and clinical experiments have confirmed that CHM for patients with CVD is safe and feasible. With the development of modern
scientific techniques, we hope that the effectiveness and safety of CHM treatment CVD can be improved in the near future. However, we also
acknowledge that the bibliometric method has some limitations. The PubMed database has a bias in favor of journals published in English.
Therefore, nations with a strong traditional of publishing in their native languages may be underestimated in comparative studies. As some of the
literature could not be calculated, evidence for its effectiveness is limited. In spite of these limitations, this study is believed to be useful for
researchers to improve their performance in the field of CHM research and new drug discovery.
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